Product information

From Health Canada

No match found

No other product was found with the same active ingredient group.

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

1976-12-31

Original market date: See footnote 1

1976-12-31

Product name:

LIGNOSPAN FORTE

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

00375799

Product Monograph/Veterinary Labelling:

Date: 2015-06-30 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

SEPTODONT
58 Rue Du Pont De Creteil
St-Maur-Des-Fosses
Val-De-Marne
France 94107

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Block/Infiltration

Number of active ingredient(s):

2

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

72:00.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

N01BB52 LIDOCAINE, COMBINATIONS

Active ingredient group (AIG) number:See footnote5

0201284011

List of active ingredient(s)
Active ingredient(s) Strength
EPINEPHRINE (EPINEPHRINE BITARTRATE) 36 MCG / 1.8 ML
LIDOCAINE HYDROCHLORIDE 36 MG / 1.8 ML
Version 4.0.2
Date modified: